Harrow, Inc. HROW 深 沪
等待开盘 04-01 09:30:00 美东时间
35.26
+1.960
+5.89%
华盛通- 最 高35.63
- 今 开34.33
- 成交量 59.16万股
- 最 低 34.00
- 昨 收 33.30
- 总市值 13.13亿
- 52周最高 54.85
- 市盈率 静 --
- 换手率 1.59%
- 52周最低 21.12
- 委 比 -18.54%
- 总股本 3722.97万
- 历史最高 59.23
- 量 比 0.99
- 振 幅 4.89%
- 历史最低 3.33
- 每 手 1
- 风险率 8.31%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Harrow announces $50M add-on senior notes offering
Harrow (NASDAQ: HROW) announced on Tuesday that it intends to offer an additional $50M in 8.625% senior unsecured notes due 2030, subject to market and other conditions. The company said the notes wil...
03-24 21:16
Harrow Announces Additional $50M Note Offering; 8.625% Senior Unsecured Notes Due 2030
The 2030 Notes will be guaranteed on a senior unsecured basis by the Company's existing and future wholly-owned domestic restricted subsidiaries and any of its other restricted subsidiaries that guarantees or co-issues
03-24 20:18
美股大行评级 | 最高700美元！大摩、瑞银等10家大行集体上调美光目标价；通用磨坊、梅西百货、SailPoint等遭多家大行下调目标价
今日重点评级关注：RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从32美元升至35美元；巴克莱：维持CytomX医疗"超配"评级，目标价从10美元升至16美元
03-20 15:53
美股大行评级 | 超多下调！露露乐蒙、Oklo、腾讯音乐、Docusign、BOBS、Bicycle、Academy Sports等遭多家大行下调目标价
今日重点评级关注：花旗：维持Candel Therapeutics"买入"评级，目标价从22美元升至26美元；Chardan Capital：维持CervoMed"买入"评级，目标价从15美元升至21美元
03-19 14:31
BTIG Reiterates Buy on Harrow, Maintains $63 Price Target
BTIG analyst Thomas Shrader reiterates Harrow (NASDAQ:HROW) with a Buy and maintains $63 price target.
03-18 23:58
美股周涨跌榜 | DAWN周涨一倍，获国际制药集团Servier溢价收购；Ziff Davis周涨56.3%
DAWN周涨一倍，获国际制药集团Servier溢价收购；Ziff Davis周涨56.3%，将其下属部门出售给埃森哲，获巴克莱上调其目标价；TNGX周涨52.1%，Q4亏损同比收窄超预期>>
03-07 10:50
美股大行评级 | 7家上调，3家下调！CrowdStrike绩后大行评级现分歧；罗斯百货、塔吉特、Viking获多家大行上调目标价
今日重点评级关注：古根海姆：维持Dianthus Therapeutics"买入"评级，目标价从100美元升至200美元；HC Wainwright & Co.：维持Amylyx Pharmaceuticals"买入"评级，目标价从28美元升至34美元
03-05 13:56
These Analysts Revise Their Forecasts On Harrow Following Q4 Results
Harrow Inc. (NASDAQ:HROW) posted mixed results for the fourth quarter on Tuesda...
03-04 22:07
Why Is Eye-Disease-Focused Harrow Stock Falling Today?
Harrow stock drops after earnings miss and weak 2026 outlook, despite revenue growth and new product plans.
03-03 21:11
Harrow Earnings Review: Q4 Summary
The earnings results for Harrow (NASDAQ:HROW) for Q4 were made public on Monday...
03-03 05:42
